Inventor · disambiguated record
Tarran Jones
Also filed as: JONES TARRAN · JONES TARRAN S
6 granted patents·4 pending applications·142 citations·filing 2004–2022
85Inventor score
Top patents by PatentIndex Score
10 records- 0196US7829086B2Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune diseaseMEDIMMUNE LLC·Filed 2007·Granted Nov 9, 2010·43 cites·24 claims
- 0294US8246958B2Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-4 antibodiesBENDIG MARY M·Filed 2008·Granted Aug 21, 2012·56 cites·9 claims
- 0392US8664363B2Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune diseaseMEDIMMUNE LLC·Filed 2013·Granted Mar 4, 2014·10 cites·9 claims
- 0486US11530257B2Chimeric antibodies for treatment of amyloid deposition diseasesUNIV COLUMBIA·Filed 2018·Granted Dec 20, 2022·5 cites·8 claims
- 0584US7435802B2Humanized anti-VLA4 immunoglobulinsELAN PHARACEUTICALS INC·Filed 2004·Granted Oct 14, 2008·21 cites·1 claims
- 0681US8389688B2Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune diseaseJONES TARRAN·Filed 2007·Granted Mar 5, 2013·7 cites·15 claims
- 0767US2023212273A1Chimeric antibodies for treatment of amyloid deposition diseasesUNIV COLUMBIA·Filed 2022·Application pending·0 cites
- 0862US2015064177A1Therapeutic uses of humanized antibodies against alpha-4 integrinBIOGEN IDEC INC·Filed 2014·Application pending·0 cites
- 0954US2013059337A1Therapeutic Uses of Humanized Antibodies Against ALPHA-4 IntegrinBENDIG MARY M·Filed 2012·Application pending·0 cites
- 1047US2011182887A1Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune diseaseMEDIMMUNE LLC·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →